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Our recent results demonstrated that bile acids facilitate virus escape from the endosomes into the
cytoplasm for successful replication of porcine enteric calicivirus (PEC). We report a novel ﬁnding that
bile acids can be substituted by cold treatment for endosomal escape and virus replication. This
endosomal escape by cold treatment or bile acids is associated with ceramide formation by acid
sphingomyelinase (ASM). ASM catalyzes hydrolysis of sphingomyelin into ceramide, which is known to
destabilize lipid bilayer. Treatment of LLC-PK cells with bile acids or cold led to ceramide formation, and
small molecule antagonists or siRNA of ASM blocked ceramide formation in the endosomes and
signiﬁcantly reduced PEC replication. Inhibition of ASM resulted in the retention of PEC, feline calicivirus
or murine norovirus in the endosomes in correlation with reduced viral replication. These results
suggest the importance of viral escape from the endosomes for the replication of various caliciviruses.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Viruses in the Caliciviridae family are small non-enveloped
viruses of 27–35 nm diameters with a single-stranded, positive-
sense RNA genome of 7–8 kb. There are at least ﬁve genera in the
Caliciviridae family: norovirus and sapovirus cause enteric infec-
tions in humans and animals, whereas lagovirus, vesivirus and
nebovirus cause a range of diverse diseases mainly in animals
(Green, 2007). Human norovirus in the Norovirus genus accounts
for about 60% of gastroenteritis cases and cause 21 million cases of
gastroenteritis and 800 deaths annually in the United States alone
(Hall et al., 2012; Scallan et al., 2011). However, research on human
norovirus has been hampered by the inability of the virus to grow
in cell culture (Duizer et al., 2004; Herbst-Kralovetz et al., 2013).
The difﬁculty in culturing human norovirus is thought to be
related to the early stage of viral replication including virus uptake
and/or uncoating process, because transfection of norovirus RNA
into cultured cells was shown to lead to virus replication and
release of viral particles into the medium (Guix et al., 2007). While
it is reported that many caliciviruses utilize host endosomal
trafﬁcking system for entry into host cells (Gerondopoulos et al.,
2010; Perry and Wobus, 2010; Stuart and Brown, 2006), little is
known about virus entry pathway of human norovirus.
After viruses are internalized into cells via the endocytic path-
ways, they must escape from the endosomal compartments to the
cytoplasm to initiate replication (Hogle, 2002; Kielian and Rey,
2006; Moyer and Nemerow, 2011). Enveloped viruses utilize
fusion machinery in their envelop protein which fuses with the
cellular membrane to release the viral genome into cytosol of host
cells (Kielian and Rey, 2006). The activation of fusion protein in the
endosomes is mediated by environmental factors including low
pH, interaction with receptor (and co-receptor), endosomal pro-
teolysis, or combination of any these factors (Chandran et al.,
2005; Earp et al., 2005; Eckert and Kim, 2001; Feng et al., 1996;
Heinz and Allison, 2000; Matsuyama et al., 2004; Mothes et al.,
2000; Skehel et al., 1982). Non-enveloped viruses lack the fusion
protein, but some viruses are known to utilize lytic factors for
membrane disruption and penetration into cell cytoplasm (Moyer
and Nemerow, 2011).
Acid sphingomyelinase (ASM) catalyzes hydrolysis of sphin-
gomyelin to ceramide. Ceramide has emerged as an important
mediator of diverse cellular effects from various stress stimuli
including bacterial or viral infection, as well as ionizing radia-
tion, UV light and heat (Gulbins and Kolesnick, 2002, 2003; He
et al., 2003; Montes et al., 2008; Stancevic and Kolesnick, 2010).
Modulation of the biophysical properties of membranes by
ceramide has been reported to be associated with formation of
small rafts that fuse together to form large ceramide-enriched
membrane platforms, changes in membrane ﬂuidity and perme-
ability, facilitation of membrane fusion, or promotion of
macropinocytosis (Basáñez et al., 1997; Gulbins et al., 2004;
Gulbins and Kolesnick, 2002; Montes et al., 2002; Siskind and
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Colombini, 2000), formation of channels large enough for
proteins to cross membranes or cause lipid ﬂip-ﬂop (Contreras
et al., 2009; Samanta et al., 2011). Ceramide or ASM has also
been shown to be required for entry of measles virus, rhino-
virus, Japanese encephalitis virus and Ebolavirus (Avota et al.,
2011; Grassmé et al., 2005; Miller et al., 2012; Tani et al., 2010).
Our previous reports have shown that bile acids facilitate the
endosomal escape of porcine enteric calicivirus (PEC, a sapo-
virus) (Shivanna et al., 2014a), but the exact mechanism
involved is not yet well understood. In this study, we demon-
strated that cold treatment (4 1C for 1 h) during PEC entry into
host cells resulted in ceramide formation in the endosomes and
viral endosomal escape and replication in the absence of bile
acid. Furthermore, PEC alone did not lead to ceramide formation
in the endosomes while bile acid- or cold-shock treatment
resulted in ASM-mediated ceramide formation in LLC-PK cells.
Interestingly, feline calicivirus (FCV, a vesivirus) or murine
norovirus-1 (MNV-1, a norovirus), that grows in the absence of
bile acids in cell culture, induced ceramide formation in the
target cells. Blocking of ceramide formation by inhibiting ASM
activity signiﬁcantly reduced the replication of PEC, FCV or
MNV-1 in the cells. We further showed that inhibition of ASM
activity lead to retention of PEC, FCV and MNV-1 in the cells by
confocal microscopy, which suggests the crucial role of cera-
mide formation by ASM in viral endosomal escape during the
early stage of calicivirus replication.
Results
Cold treatment induces PEC replication without bile acids
When cells were infected with PEC at a high MOI (50) and
incubated at 4 1C for 1 h during virus entry, replication of PEC was
evident by virus titration and IFA assay without bile acids (Fig. 1A–C).
Virus titration by real time qRT-PCR or the TCID50 method demon-
strated efﬁcient PEC replication by cold treatment that is comparable
to bile acid-mediated replication (Fig. 1A and B). Virus replication
kinetics measured by real time qRT-PCR at 1, 4, 8, and 12 h
postinfection (pi) were not different between cold treatment, bile
acid treatment or combination of two treatments (Fig. 1B). While PEC
RNA levels remain stagnant without any treatment, treatment of cells
with cold or bile acids led to an approximately 10-fold increase of
virus copy number at 8 h and up to a 100-fold increase at 12 h
compared to the untreated control (Fig. 1B). Similar PEC replication
kinetics was observed with PEC at a lower MOI of 5. However,
detection of viral replication was not consistent probably due to the
small number of viral progeny since only single cycle virus replica-
tion was allowed by one-time cold treatment in our studies (data not
shown). The IFA assay also showed PEC replication induced by cold
treatment (Fig. 1C). At 12 h pi, the expression of viral proteins, 2AB,
polymerase or VPg, was evident in the virus-infected cells treated
with cold or bile acids. However, without cold or bile acid treatment,
PEC infection even at 50 MOI did not yield any evidence for
expression of the viral proteins (Fig. 1C).
We have previously reported that bile acids facilitate viral
escape from the endosomes for replication of PEC (Shivanna
et al., 2014a). Thus we examined if cold treatment is also involved
in viral endosomal escape using the confocal microscopy. In our
previous report (Shivanna et al., 2014a), PEC particles disappeared
from the endosomes at 1 h pi in the presence of bile acids leading
to virus replication. However, PEC particles remained in the
endosomes without bile acids and failed to escape from the
endosomes for virus replication. In this study, we observed the
same phenomenon of disappearance of PEC particles at 1 h with
cold or bile acid treatment, which is in contrast to the detection of
PEC particles at 1 h pi without any treatment (Fig. 1D).
Bile acids or cold treatment induce ceramide formation through
activation of ASM
Using confocal microscopy, we ﬁrst examined if GCDCA or cold
treatment induce ceramide formation in the cells. Untreated, un-
infected LLC-PK cells had little ceramide (Fig. 2A, a–c). Likewise,
ceramide was not detected in PEC-infected (50 MOI) or untreated
cells (Fig. 2A, d–f). However, GCDCA or cold treatment induced
remarked ceramide formation in the cells (Fig. 2A, g–l). Ceramide
induced by GCDCA or cold treatment co-localized with the endoso-
mal marker Rab7 (red) (Manders split colocalization coefﬁcient of
40.90) (Fig. 2B, h and l). However, when non-permeabilized cells
were tested for ceramide, there was little ﬂuorescence signal even
after treated with GCDC or cold temperature, suggesting the cer-
amide formation may not occur on the cytoplasmic membranes.
Inhibition of ASM activity by desipramine (Kornhuber et al., 2010) or
ASM siRNA drastically reduced ceramide formation by GCDCA or cold
treatment, indicating that ceramide formation induced by bile acids
or cold treatment is mediated by ASM activity (Fig. 3). Reduction in
ASM mRNA levels in cells transfected with various concentrations of
ASM siRNA was conﬁrmed with real time qRT-PCR (490% with 100
or 200 nM of ASM siRNA) or regular RT-PCR (up to 87% as shown in
Fig. 4A).
ASM activity is required for productive calicivirus replication
ASM inhibitors or ASM siRNA were used to demonstrate the
requirement of ASM activity in PEC replication. Transfection of
ASM siRNA in cells treated with GCDCA or cold led to signiﬁcant
reduction in PEC genome by 0.9–1.1 or 0.85–0.97-fold (log10)
compared to un-transfected cells treated with GCDCA or cold,
respectively (Fig. 4B and C). However, transfection with irrelevant
siRNA did not have any effect on PEC replication. Various ASM
inhibitors, AY9944, ﬂuoxetine, desipramine and chlorpromazine,
showed similar inhibitory effects on virus replication (Fig. 4D and
E): each ASM inhibitor reduced PEC replication in cells treated
with GCDCA or cold with a reduction in PEC genome by 0.96–1.35
or 0.86–1.10-fold (log10) compared to the cells treated with GCDCA
or cold without an inhibitor, respectively (Fig. 4D and E).
FCV or MNV-1 infections induce ceramide formation in the target cells
and inhibition of ASM signiﬁcantly reduces their replication
Since FCV or MNV-1 does not require bile acids for replication,
we hypothesized that FCV or MNV-1 infection itself induces
ceramide formation during virus entry process. Incubation of CRFK
or RAW267.4 cells with FCV (MOI 50) or MNV-1 (MOI 30) at 37 1C
for 1 h, respectively, led to prominent ceramide formation in the
permeabilized cells (Fig. 5A, d–f and i–k). However, little ceramide
was detected in uninfected cells (Fig. 5A, b and h), when viruses
were inoculated to non-permissive cells (e.g. FCV in RAW264.7
cells) or in non-permeabilized cells. Interestingly, BEI-inactivated
FCV or MNV-1 also induced ceramide formation in their respective
permissive cells (Fig. 5B, b and e). As shown for live viruses,
desipramine also blocked ceramide formation by inactivated FCV
or MNV-1 in CRFK or RAW264.7 cells, respectively (Fig. 5B, h and
k). Inhibition of ceramide formation by ASM inhibitors also
reduced FCV or MNV-1 replication: ASM inhibitors decreased
FCV or MNV-1 replication by 100–375.1- or 100–211.3-fold in
TCID50 titers, respectively (Fig. 6A and B).
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Fig. 1. Effects of cold treatment in PEC replication and viral escape from the endosomes. (A) Conﬂuent LLC-PK cells were infected with PEC (MOI 50) with no treatment (virus
only), GCDCA (100 mM) or cold treatment (4 1C, 1 h) and virus replication was determined by TCID50 method after 16 h. An asterisk indicates a signiﬁcant difference
(po0.05) between the groups, and n.s. no signiﬁcance difference. (B) LLC-PK cells were inoculated with PEC at an MOI of 50 with GCDCA (100 mM) or cold treatment (4 1C,
1 h). PEC RNA was quantiﬁed by qRT-PCR at 1, 4, 8 and 12 h postvirus infection. An asterisk indicates a signiﬁcant difference (po0.05) compared to virus only (untreated)
group. (C) LLC-PK cells were inoculated with PEC (MOI 50) and incubated at 4 1C (cold treatment) or 37 1C (control) for 1 h. Cells were ﬁxed at 12 h and expression of 2AB,
polymerase (RdRp) or VPg was determined. (D) Confocal laser scanning microscopic examination on PEC entry by various treatments. LLC-PK cells grown on Lab-Tek II CC2
chamber slides were infected either with Mock (medium) or PEC (MOI 50) with no treatment (PEC), GCDCA (100 mM) or cold treatment (4 1C, 1 h). Following 1 h incubation,
cells were incubated for additional 1 h at 37 1C. Cells were then ﬁxed for confocal microscopy. Nuclei were stained with sytox orange (5 mM) (pseudocolored blue), and PEC
was probed with swine polyclonal anti-PEC primary antibodies and detected by FITC labeled goat-anti-swine antibody (green). Merged images for nuclei and PEC were
prepared.
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Ceramide formation is required for entry of calicivirus into host cells
We have previously reported that endosomal uptake and sub-
sequent endosomal escape of PEC and MNV-1 is critical for virus
replication by showing that PEC and MNV-1 particles colocalized
with the endosomal marker Rab7 disappears at 1 h pi, leading to
virus replication, while PEC or MNV-1 remaining in the endosomes
failed to lead to virus replication (Shivanna et al., 2014b). In this
study, we tested the hypothesis that ceramide formation, which is
known to trigger membrane destabilization, may facilitate escape of
calicivirus from the endosomes during virus entry. Inhibition of ASM
by an inhibitor or siRNA led to retention of ﬂuorescence signals for
PEC even in the presence of GCDCA or cold treatment at 1 h pi
(Fig. 7A), which correlated with reduced PEC replication (Fig. 4B–E).
Without ASM inhibition, ﬂuorescence signals for PEC capsid protein
disappeared in the cells treated with GCDCA or cold (Fig. 1D, f–k), and
the location of the PEC particles was reported to be in the endosomes
in our previous report (Shivanna et al., 2014a, b). Similar
GCDCA 
Cold 
treatment 
Mock
CeramideNuclei Merge
PEC
GCDCA
Cold 
treatment 
Mock
CeramideNuclei Rab7
Merge 
(ceramide+Rab7)
l
Fig. 2. Ceramide formation by bile acids or cold treatment in LLC-PK cells. Ceramide formation by bile acids or cold treatment in LLC-PK cells. (A) LLC-PK cells were incubated
with medium (Mock) (a–c), PEC (MOI 50) (d–f), GCDCA (100 mM, at 37 1C) (g–i) or cold treatment (4 1C for 1 h) (j–l). Cells were transferred to 37 1C, and incubated for 1 h.
Then, cells were ﬁxed and probed with mouse IgM anti-ceramide antibody and goat-anti-rabbit antibody (green) for ceramide or stained with sytox orange (5 mM,
pseudocolored blue) for nuclei, and merged images were prepared. (B) LLC-PK cells were treated with Mock, GCDCA or cold and ﬁxed as in (A). Rab7 was probed with rabbit
polyclonal anti-Rab7 with PerCP-Cy5.5 labeled goat-anti-rabbit antibody. Colocalization images of ceramide (green) with Rab7 (red) were prepared from cross-sections
above nuclei for better resolution and analyzed using ImageJ. Colocalization of ceramide with Rab7 appears in white in the merged images.
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phenomenon was observed for FCV or MNV-1 with confocal studies:
the ﬂuorescence signals for their capsid proteins disappeared in the
cells at 1 h pi (Fig. 7B, a–c for FCV and g–i for MNV-1) when ASM
activity was intact. However, marked accumulation of FCV or MNV-1
capsid proteins were observed in CRFK or RAW267.4 cells, respec-
tively, in the presence of an ASM inhibitor (Fig. 7B, d–f or j–l). This
observation also correlates well with the reduction in FCV or MNV-1
replication by ASM inhibitors (Fig. 6). These results suggest the
requirement of ceramide formation by ASM for successful viral
escape from the endosomes during the entry of these caliciviruses.
Discussion
While a recent report suggested that human noroviruses may
infect B cells (Jones et al., 2014), there is no practical cell culture
system for the important enteric pathogens. Virus entry step is
implicated in the inability of human norovirus to propagate in cell
culture since transfection of human norovirus RNA into cultured
cells produces infectious virus progeny (Guix et al., 2007). PEC
RNA, once delivered into the cells by transfection, is also capable of
producing infectious viruses, indicating that virus entry is the
limiting step in PEC replication (Shivanna et al., 2014a). However,
PEC is able to propagate in the cells in the presence of bile acids,
which suggest that bile acids are involved in PEC entry. We have
recently demonstrated that bile acids facilitate viral endosomal
escape from the endosomes and PEC particles are trapped in the
endosomes without bile acids (Shivanna et al., 2014a). The
requirement of bile acids is unique for PEC replication and other
cultivable caliciviruses, FCV and MNV-1, does not require any
supplement in cell culture for virus propagation (Kreutz and
Seal, 1995; Perry and Wobus, 2010; Stuart and Brown, 2006).
These ﬁndings illustrate that understanding the molecular basis of
viral entry process may lead to the development of a better cell
culture model for human noroviruses and other uncultivable
enteric viruses.
Our initial attempts to synchronize PEC entry using high MOI
(410) into LLC-PK cells by incubating the cells inoculated with
viruses at 4 1C and then at 37 1C resulted in unexpected PEC
replication in the absence of bile acids (Fig. 1). Since single cold
treatment was applied to PEC culture, high MOI infections made it
easy to detect the expression of PEC non-structural proteins
(Fig. 1C), however, PEC replication can be initiated with
cold treatment at various MOI. As it was observed with bile acids
that facilitated the endocytic escape of PEC in cells (Shivanna
et al., 2014a), cold treatment of cells incubated with PEC allowed
disintegration of PEC particles and subsequent virus replication.
These ﬁndings suggest that bile acids and cold treatment
may trigger the same endocytic escape mechanism in LLC-PK
cells.
CeramideNuclei Merge
PEC + GCDCA +
Desipramine
PEC+ 
Cold treatment
+ Desipramine
PEC + GCDCA +
ASM siRNA
PEC+ 
Cold  treatment 
+ ASM siRNA
PEC + GCDCA
Fig. 3. Effects of ASM on ceramide formation in LLC-PK cells by GCDCA or cold treatment. Conﬂuent cells were inoculated with PEC (50 MOI) and subject to GCDCA (100 mM,
37 1C for 1 h, a–h) or cold treatment (4 1C for 1 h, i–n) in the presence or absence of an ASM inhibitor (desipramine, 40 mM) or ASM siRNA (200 nM, transfected at 48 h prior
virus infection) for 1 h. Cells were then further incubated at 37 1C for 1 h and were ﬁxed for confocal microscopy. Individual or merged images for nuclei (blue) and ceramide
(green) were prepared.
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ASM activation is induced in response to various cellular stress
stimuli such as cold temperature, irradiation and infection to
produce ceramide which is involved in various signaling path-
ways (Montes et al., 2008; Zeidan and Hannun, 2010; Zhang et al.,
2001). ASM-mediated ceramide formation has also been reported
to play an important role in the replication of some viruses (Avota
et al., 2011; Grassmé et al., 2005; Miller et al., 2012; Tani et al.,
2010). Since bile acids and cold treatment are able to induce ASM
activation (Gupta et al., 2004; Montes et al., 2008) and ceramide
formation is known to be important in the replication of multiple
viruses, we hypothesized that ASM activation and ceramide
production is involved in cold- or bile acids-mediated PEC entry
and replication. Using the confocal microscopy, we found that cold
treatment or bile acids induced ceramide formation in the
endosomal-like compartments, whereas PEC alone had little effect
(Fig. 2A and B). This ceramide formation by bile acids or cold
temperature and PEC replication required intact ASM activity,
which was demonstrated by the inhibition studies using ASM
inhibitors and siRNA in LLC-PK cells (Figs. 3 and 4).
Since ASM-mediated ceramide formation is found to be impor-
tant in endocytic escape and replication of PEC, we extended our
studies to other caliciviruses, FCV and MNV-1. FCV and MNV-1
utilize endocytic pathway for entry and readily propagate in cell
culture without any supplement (Gerondopoulos et al., 2010;
Perry and Wobus, 2010; Stuart and Brown, 2006). However, it is
not yet known what factors are involved during endosomal escape
of these caliciviruses. In this study, incubation of live or inactivated
FCV or MNV-1 with CRFK or RAW267.4 cells, respectively, at 37 1C
for 1 h led to ceramide formation (Fig. 5A and B). However, there
was no evidence of ceramide formation when viruses were
incubated with the cells that do not allow virus replication (non-
permissive cells). These results suggest that ceramide formation
occurs prior to or in the absence of active virus replication in
permissive cells (Fig. 5B). As was the case with PEC, ceramide
formation and virus replication was mediated by ASM activation as
demonstrated by ASM inhibitor studies (Figs. 5B and 6). These
results on PEC, FCV and MNV-1 indicate that ASM-mediated
ceramide formation by virus infection itself or other extraneous
factors is critical for successful virus replication for these
caliciviruses.
Next, the role of ASM-mediated ceramide formation in virus
entry was studied. On confocal microscopy, virus particles dis-
appeared in the cytoplasm at 1 h pi and virus replication success-
fully ensued when ASM activity was not inhibited. However, PEC,
FCV or MNV-1 particles are still observed at 1 h pi when ASM
activity was blocked by an inhibitor or siRNA (Fig. 7). Previously,
we have reported that absence of bile acids in the culture media
leads to PEC retention in the endosomes and failed virus replica-
tion in LLC-PK cells, which indicate that bile acids are required for
endocytic escape of PEC into cytoplasm (Shivanna et al., 2014a).
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Fig. 4. Effects of siRNA or inhibitors of ASM on PEC replication. (A) After the
transfection of ASM-speciﬁc (at various concentrations) or irrelevant siRNA, ASM
mRNA was ampliﬁed by RT-PCR for 25 cycles, and the RT-PCR products on agarose
gel were quantiﬁed by densitometric analysis using imageJ software. (B, C) LLC-PK
cells were transfected with Mock, irrelevant siRNA or ASM siRNA and incubated for
48 h. Then cells were inoculated with PEC at an MOI of 50 and treated with GCDCA
(100 mM, 37 1C for 1 h) or cold (4 1C for 1 h). After further incubated at 37 1C for 1 h,
cells were washed with PBS, and incubated at 37 1C for 12 h. Viral replication was
determined by real time qRT-PCR. (D, E) Conﬂuent LLC-PK cells were pretreated
with various ASM inhibitors at different concentrations at 37 1C for 1 h, followed by
inoculation with PEC (MOI 50) with GCDCA (100 mM, 37 1C for 1 h, D) or cold (4 1C
for 1 h, E). Following 1 h incubation, cells were further incubated at 37 1C for 1 h
and washed with PBS. Cells were then added with fresh media containing
inhibitors and further incubated for 12 h, at which time, viral replication was
quantiﬁed by real time qRT-PCR. An asterisk indicates a signiﬁcant difference
between the groups (po0.05).
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Fig. 5. Ceramide formation by incubation of cells with live or inactivated FCV or MNV-1. (A) CRFK or RAW264.7 cells were inoculated with medium (Mock, a–c or f–h), FCV
(50 MOI, d–f) or MNV-1 (30 MOI, i–k) and incubated at 37 1C for 1 h. Cells were then ﬁxed for confocal microscopy. (B) CRFK or RAW264.7 cells were incubated with
inactivated FCV (50 MOI equivalent, a–c) or inactivated MNV-1 (30 MOI equivalent, d–f) or cells were infected with FCV (50 MOI) or MNV-1 (30 MOI) with or without
desipramine (45 mM) at 37 1C for 1 h. Cells were then ﬁxed and stained with sytox orange (5 mM, pseudocolored blue) for nuclei or probed with mouse IgM anti-ceramide
antibody and goat-anti-rabbit antibody (green) for ceramide. Merged images of ceramide (green) with nuclei (blue) were prepared.
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Findings from the previous and current studies indicate that
calicivirus entry requires activation of ASM which induces cer-
amide formation in the endosomes and ceramide formation is
involved in viral endosomal escape.
The importance of ASM and ceramide in virus replication has
been previously reported (Grassmé et al., 2005; Jan et al., 2000;
Miller et al., 2012; Tani et al., 2010). Semliki Forest virus requires
the presence of ceramide in the cell membrane for virus-cell
fusion (Nieva et al., 1994). ASM function is required for enhance-
ment of viral uptake of Ebolavirus, measles virus and rhinoviruses,
as well as for other virus-induced cellular effects (Avota et al.,
2011; Grassmé et al., 2005; Miller et al., 2012). Since formation of
ceramide platforms was shown to alter membrane ﬂuidity and
permeability to form large channels or cause lipid ﬂip-ﬂop along
with its hydrophobic protein interaction site (Contreras et al.,
2009; Krönke, 1999; Montes et al., 2002; Samanta et al., 2011), it is
speculated that modiﬁcation of lipid organization in the cellular
membranes may contribute to viral translocation into the cyto-
plasm. In this study, we made a novel ﬁnding that caliciviruses,
PEC, MNV-1 and FCV, require ASM-mediated ceramide formation
for productive virus replication in cell culture system. While we
found that bile acids or cold treatment triggers ceramide forma-
tion in PEC-infected cells, it is not yet known how the interaction
between MNV-1 or FCV and host cell leads to ASM activation. The
cellular receptor(s) for PEC or MNV-1 are not well known to date
but the receptor for FCV was identiﬁed as feline junctional
adhesion molecule (fJAM-A) (Ossiboff and Parker, 2007). JAM-A
is a multifunctional cell surface protein and JAM-A of murine or
human origin forms a complex with phosphokinase C (PKC) (Iden
et al., 2012). Since some PKC isoforms are capable of activating
ASM, it can be speculated that interaction of FCV and fJAM-A may
lead to activation of ASM through a PKC isoform. However, the
mechanisms of ASM activation by virus–cell interaction remain to
be determined.
In summary, we demonstrated that activation of ASM by bile
acids (PEC) or virus (FCV or MNV-1) led to ceramide formation on
the endosomal membranes, facilitating viral endosomal escape,
and inhibition of this event signiﬁcantly reduced viral replication.
Virus entry for caliciviruses is a complex process involving
uncoating of virus capsid proteins and translocation of genetic
material across the endosomal membrane into cytoplasm for
initiation of virus replication. We have recently reported that
caliciviruses such as PEC, FCV and MNV-1 require cathepsin L
activity and adequate endosomal environment (low pH) for
endocytic viral escape and successful virus replication (Shivanna
et al., 2014b). Our previous ﬁndings and the results from this study
indicate that calicivirus entry into host cells is multi-step pro-
cesses involving cleavage of capsid proteins by cellular protease
and ceramide formation, which eventually leads to release of viral
genome into cytoplasm. How these events are coordinated during
calicivirus entry process warrants further studies. Nevertheless,
these results suggest that a common mechanism is utilized by
caliciviruses during virus entry into host cells and contribute to
our understanding of calicivirus entry process.
Materials and methods
Cells and viruses
PEC Cowden strain was propagated in LLC-PK cells in the
presence of glycochenodeoxycholic acid (GCDCA, 100 mM) (Chang
et al., 2004) in Eagle's Minimal Essential Medium (MEM) supple-
mented with 5% fetal bovine serum, 100 U/ml penicillin and
100 mg/ml streptomycin. FCV Urbana strain was propagated in
CRFK cells in MEM containing 5% fetal bovine serum, 100 U/ml
penicillin and 100 mg/ml streptomycin. MNV-1 was propagated in
RAW264.7 cells in Dulbecco's modiﬁed Eagle's medium (DMEM)
supplemented with 5% fetal bovine serum, 100 U/ml penicillin and
100 mg/ml streptomycin. The cultured viruses were concentrated
by centrifugation at 27,000 rpm through a 40% w/v sucrose
cushion at 4 1C for 2 h in a SW27 rotor. The obtained pellet was
resuspended in serum free MEM and stored in 80 1C.
Reagents and antibodies
GCDCA and bromoethylamine hydrobromide was purchased
from Sigma-Aldrich (St Louis, MO). AY9944, an ASM inhibitor, was
purchased from Santa Cruz Biotech (Santa Cruz, CA). Other ASM
inhibitors including ﬂuoxetine, desipramine, chlorpromazine were
purchased from Sigma-Aldrich. For confocal microscopy, anti-PEC/
cowden antibodies raised in swine (Chang et al., 2005), anti-FCV
antibodies raised in guinea pig (Sosnovtsev and Green, 1995), anti-
MNV-1 antibodies raised in guinea pig (Wobus et al., 2004), mouse
IgM anti-ceramide antibody from Enzo Life Sciences, Inc (Farm-
ingdale, NY) and rabbit polyclonal IgG anti-Rab7 antibodies
purchased from Santa Cruz Biotech were used as the primary
antibodies. The secondary antibodies used include PerCP-Cy5.5
anti-rabbit from Santa Cruz Biotech, FITC anti-swine IgG and FITC
anti-mouse purchased from Kirkegaard and Perry Lab (Gaithers-
burg, MD) and FITC-anti-guinea pig IgG from Sigma-Aldrich.
Additional PEC antibodies including anti-2AB, RdRp or VPg were
described previously (Chang et al., 2005).
FCV + + + + +
AY 9944 - 45 µM - - -
Fluoxetine - - 30 µM - -
Desipramine - - - 45 µM -
Chloropromazine - - - - 5 µg/ml
MNV + + + + +
AY 9944 - 45 µM - - -
Fluoxetine - - 30 µM - -
Desipramine - - - 45 µM -
Chloropromazine - - - - 5 µg/ml
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Fig. 6. The effects of ASM inhibitors in the replication of FCV or MNV-1. Conﬂuent
CRFK or RAW264.7 cells were pretreated with various ASM inhibitors at different
concentrations at 37 1C for 1 h, followed by inoculation with FCV (MOI 50) or MNV-
1 (30 MOI), respectively. Cells were then incubated further at 37 1C for 1 h, washed
with PBS. After washing, fresh media containing the same inhibitors were added to
the cells. Cells were then further incubated at 37 1C for 12 h. Viral replication was
assessed with titration with TCID50 method. An asterisk indicates a signiﬁcant
difference between the groups (po0.05).
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PEC + GCDCA +
Desipramine
PEC + Cold treatment
+Desipramine 
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PEC + GCDCA +
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MNV-1 +
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Fig. 7. Effects of ASM inhibition on the detection of PEC, FCV or MNV-1 during virus entry by confocal microscopy. (A) LLC-PK cells were inoculated with PEC (50 MOI) and
treated with GCDCA (100 mM, 37 1C for 1 h) or cold (4 1C for 1 h) with desipramine (45 mM) or ASM siRNA (200 nM) as described in the text. After additional incubation at
37 1C for 1 h, cells were ﬁxed for confocal microscopy. (B) CRFK or RAW264.7 cells were inoculated with either FCV or MNV-1, respectively with or without desipramine
(45 mM). Fixed cells were probed with PEC, FCV or MNV-1 antibody with the secondary antibody (green) for virus as described above or in text. Merged images of virus
(green) with nuclei (blue) were prepared.
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Infection and replication of PEC
Conﬂuent LLC-PK cells were inoculated with PEC at an MOI of
50 in the absence or presence of GCDCA (100 mM) and incubated at
4 1C or 37 1C for 1 h. Following 1 h incubation, the plates were
immediately transferred to 37 1C, and incubated for additional 1 h.
Then, virus infected cells were thoroughly washed twice with PBS,
replenished with MEM containing 5% FBS, and further incubated at
37 1C for 12 h or other indicated time. Viral replication was
quantiﬁed by real-time qRT-PCR (Shivanna et al., 2014a) or by
the TCID50 assay (Reed and Muench, 1938). Total RNA was
extracted from the cells (before extensive cell lysis) for real time
qRT-PCR or the cells were disrupted with 3 cycles of freezing/
thawing, and supernatant was used for virus titration by the
TCID50 assay. Viral replication by cold treatment was also evalu-
ated with immunoﬂuorescence assay (IFA). Cells were inoculated
with PEC at an MOI of 50, incubated at 4 1C or 37 1C for 1 h, and
then incubated at 37 1C for 12 h. The infected cells were ﬁxed with
chilled methanol, and stained with PEC antibody (anti-2AB, RdRp
or VPg) and FITC-conjugated rabbit anti-guinea pig IgG antibody.
Inhibition of ASM by siRNA or small molecule inhibitors
ASM siRNA and primers/probes for qRT-PCR for ASM were
designed based on the porcine ASM gene (GenBank accession no.
XM_005656607) and synthesized by Integrated DNA technology
(Coralville, IA). The porcine ASM siRNAs were 50-rArUrUrCrGr-
GrUrArArUrArArUrUrCrCrArG and 50-rGrCrUrGrGrArGrCrUrGr-
GrArUrUrArU. For siRNA studies, one-day old LLC-PK cells were
transfected with Mock (transfection agent), irrelevant siRNA
(negative control from Qiagen) or ASM siRNA, followed by incuba-
tion at 37 1C for 48 h. Following transfection and incubation, ASM
speciﬁc mRNA levels were quantiﬁed by real-time qRT-PCR using
primers: F-50-CCTTCGCACCCTCAGAATC, R-50-CAGAAGTTCTCACGG-
GAACAA, and Probe: 50-56-FAM/ATTGAGAGA/ZEN/GATGAGGCG-
GAGGC/3IABkFQ/-30. The RT-PCR products were also run on
agarose gels to measure ASM mRNA levels. At 48 h posttransfec-
tion, cells were inoculated with PEC at an MOI of 50 in the
presence of GCDCA (100 mM, 37 1C) or treated with cold (4 1C)
for 1 h. Cells were then further incubated at 37 1C for 1 h, and
washed with PBS. After washing, fresh media was added to cells
and virus infected cells were further incubated for 1 h (for confocal
study) or 12 h (for viral replication study). Inhibitors of ASM
including AY9944, ﬂuoxetine, desipramine and chlorpromazine
were also used to examine their effects on ceramide formation and
viral replication. For this inhibition study, optimal concentration of
each ASM inhibitor was determined by examining the cytotoxic
effects and the effects on ceramide formation and virus replica-
tion: 45 mM for AY9944, 35 mM for ﬂuoxetine, 45 mM for desipra-
mine, and 7.5 mg/ml for chlorpromazine. LLC-PK cells were treated
with each compound at 37 1C for 1 h. Cells were then inoculated
with PEC at an MOI of 50 and further incubated at 37 1C in the
presence of GCDCA (100 mM) for 1 h or subject to cold treatment at
4 1C for 1 h. Following 1 h incubation, cells were washed with PBS
and fresh media were added to cells with or without an inhibitor.
Cells were then further incubated at 37 1C for 1 h (for confocal
study) or 12 h (viral replication study).
Inactivation of FCV and MNV-1
The harvested virus suspension was centrifuged at 3000 rpm
for 15 min to remove cell debris. The resulting supernatant virus
suspension was mixed with fresh binary ethylenimine (BEI) at the
ratio of 9:1 (0.1 M solution of bromoethylamine hydrobromide in
0.2 N NaOH cyclized to BEI by incubating at 37 1C for 1 h in a water
bath). The treated virus suspension was stirred for 24 h at 37 1C.
BEI is then inactivated by adding fresh ﬁlter sterilized sodium
thiosulfate (1.0 M solution) at a rate of 30 ml per liter to make
0.03 M concentration. The mixture was mixed for 2–4 h at 37 1C
and the pH was adjusted to 6.6–7.2 with 4 N HCl. The inactivated
virus suspension is then concentrated by spinning at 27,000 rpm
through a 40% sucrose cushion at 4 1C for 2 h in a SW27 rotor.
The resulting pellet was resuspended in MEM and stored at 4 1C.
Inactivation of FCV or MNV-1 was conﬁrmed by inoculating CRFK
or RAW264.7 cells with the inactivated viruses.
FCV or MNV-1 infection
To study ceramide formation by FCV or MNV-1 infections,
conﬂuent CRFK or RAW267.4 cells were inoculated with Mock-
medium (Mock) or high MOI of FCV (50 MOI) or MNV-1 (30 MOI),
respectively, and incubated at 37 1C for 1 h. Inactivated FCV or
MNV-1 was inoculated to CRFK and RAW267.4 (both target and
non-target cells) at the same MOI used with live viruses. To test
ASM activity on ceramide formation, inhibitors of ASM including
AY9944, ﬂuoxetine, desipramine and chlorpromazine were used
for FCV or MNV-1 infection studies. Brieﬂy, conﬂuent CRFK and
RAW267.4 cells were pretreated with each ASM inhibitor (AY9944
45 mM, ﬂuoxetine 35 mM, desipramine 45 mM, chlorpromazine
7.5 mg/ml) at 37 1C for 1 h. At this concentration, no cytotoxicity
was observed. Cells were then inoculated with FCV (MOI 50) or
MNV-1 (MOI 30) in presence of the inhibitor at 37 1C for 1 h.
Following 1 h incubation, virus-infected cells were washed twice
with PBS and replenished with fresh MEM containing the same
concentration of ASM inhibitor. Cells were further incubated at
37 1C for 12 h and the replication of FCV or MNV-1 was deter-
mined by the TCID50 assay.
Confocal microscopy
For confocal microscopy, cells were ﬁxed in 4% paraformalde-
hyde (Sigma-Aldrich) in PBS (pH 7.4) at room temperature (RT) for
15 min, permeabilized with 0.1% Triton 100 in PBS for 10 min at
RT, washed three times with PBS, and incubated in blocking buffer
(PBS containing 0.5% bovine serum albumin) for 15 min. Also ﬁxed
cells without permeabilization were prepared as a control. The
cells were then incubated with primary antibodies speciﬁc to the
capsid protein of PEC (1:200), MNV-1 (1:200) or FCV (1:200), or
Rab7 (1:200) at 37 1C to probe PEC, MNV-1, FCV or endosomes,
respectively. After 2 h incubation at 37 1C, cells were washed three
times with PBS and further incubated at 37 1C for 2 h with
appropriate secondary antibodies. Cellular DNA was stained with
sytox orange (0.5 mM in 0.9% NaCl). Coverslips were mounted in
Prolong Gold antifade reagent (Molecular Probes), and the cells
were scanned with a confocal microscope LSM 510 (Zeiss, Ober-
kochen, Germany) using a 100 oil-immersion objective. The
images were analyzed by ImageJ software 1.47 (http://imagej.nih.
gov/ij/), and merged images were prepared. For the colocalization
of ceramide and Rab7, colocalization analysis was performed using
JACoP and colocalization-MBF plugins for ImageJ software. Single
channel images were thresholded by Costes' auto threshold
method and the Manders split correlation coefﬁcient for colocali-
zation was then determined for each image.
Statistical analysis
All the results shown are the means and the standard errors of
the means from at least three independent experiments. The
effects of ASM siRNA and ASM inhibitors were analyzed by two-
tailed Student's t-test. p Value o0.05 was considered statistically
signiﬁcant. Confocal images shown are representative of at least
three independent experiments.
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